RecruitingNot ApplicableNCT07662603

Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing


Sponsor

Cairo University

Enrollment

40 participants

Start Date

May 6, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated


Eligibility

Min Age: 13 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying inspiratory muscle trianing for people with behcet disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 13 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERinspiratory muscle trianing

twenty Behcet disease patients with pulmonary endoarterectomy will be will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week)


Locations(1)

Cairo University

Giza, Dokki, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07662603


Related Trials